1-6 of 6
hmgn1 protein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Role for HMGN1 in Down Syndrome Acute Lymphoblastic Leukemia

Elyse C Page, BSc, Susan L Heatley, PhD MD, David T Yeung, PhDBSc,FRACP,FRCPA,MBBS, Paul Q Thomas, PhD, Deborah L. White, PhD FFSc (RCPA)
Journal: Blood
Blood (2019) 134 (Supplement_1): 1462.
https://doi.org/10.1182/blood-2019-126244
Published: 2019
Journal Articles

Nucleosome Binding Protein HMGN1 Promotes HSPC Competitive Advantage with Decreased Quiescence and Cooperates with AML Oncogenes to Block Differentiation and Increase Clonogenicity

Lucia Cabal-Hierro, PhD, Katsuhiro Togami, MD PhD, Kelly Higby, Andrew A. Lane, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2606.
https://doi.org/10.1182/blood-2018-99-119348
Published: 2018
Journal Articles

Comprehensive Genomic Analysis Identified Acute Lymphoblastic Leukemia in Down Syndrome Was Highly Heterogeneous with the High Prevalence of Ph-like Signature

Yasuo Kubota, MD, Kumiko Uryu, MD PhD, Tatsuya Ito, MD, Masafumi Seki, MD,PhD, Tomoya Isobe, MD, Tsutomu Toki, PhD, Kenichi Yoshida, MD PhD, Yuichi Shiraishi, PhD, Kenichi Chiba, PhD, Hiroko Tanaka, BA, MItsuteru Hiwatari, MD PhD, Satoru Miyano, PhD, Akira Oka, MD PhD, Seishi Ogawa, MD PhD, Kiminori Terui, MD PhD, Atsushi Sato, MD, Etsuro Ito, MD PhD, Junko Takita, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2817.
https://doi.org/10.1182/blood-2018-99-111080
Published: 2018
Journal Articles

DYRK1A Is a Therapeutic Target in B-ALL in Children with Down Syndrome

Paul Lee, MD PhD, Rahul Bhansali, BA, Malini Rammohan, BS, MS, Nobuko Hijiya, MD, Shai Izraeli, MD Prof, Jean-Pierre Bourquin, MD PhD, Sebastien Malinge, PhD, John Crispino, PhD MBA
Journal: Blood
Blood (2016) 128 (22): 2721.
https://doi.org/10.1182/blood.V128.22.2721.2721
Published: 2016
Journal Articles

Gene Expression Profiles and Methylation Analysis in Down Syndrome Related Acute Lymphoblastic Leukemia

Yasuo Kubota, MD, Kumiko Uryu, MD, Tomoko Kawai, Tatsuya Ito, MD, Isamu Hanada, MD PhD, Tsutomu Toki, PhD, Masafumi Seki, MD PhD, Kenichi Yoshida, MD PhD, Keisuke Kataoka, MD PhD, Yuichi Shiraishi, PhD, Kenichi Chiba, BA, Hiroko Tanaka, BA, Satoru Miyano, PhD, Akira Oka, MD PhD, Yasuhide Hayashi, MD PhD, Seishi Ogawa, MD PhD, Kiminori Terui, MD PhD, Atsushi Sato, MD PhD, Kenichiro Hata, Etsuro Ito, MD PhD, Junko Takita, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4084.
https://doi.org/10.1182/blood.V128.22.4084.4084
Published: 2016
Journal Articles

Protein Interaction Partners of PDZ-Binding Kinase (PBK) Implicate a Possible Role in Leukemogenesis.

Asit K. Nandi, PhD, Tamara Ford, Daniel Fleksher, Brian Neuman, Aaron P. Rapoport, M.D
Journal: Blood
Blood (2006) 108 (11): 4318.
https://doi.org/10.1182/blood.V108.11.4318.4318
Published: 2006